Table 4 ROC evaluations performed between normal and MASLD.
From: Metabolic and hepatic biomarkers associated with MASLD in the Chinese population
Variable | AUC (95% CI) | Sensitivity | Specificity | Cut-off |
|---|---|---|---|---|
ALT | 0.775 (0.772–0.778) | 71.7% | 69.6% | 20.4 |
AST | 0.670 (0.667–0.674) | 59.2% | 66.0% | 22.0 |
AST/ALT | 0.780 (0.777–0.783) | 71.4% | 71.2% | 1.1 |
FBG | 0.630 (0.624–0.636) | 52.0% | 67.2% | 5.4 |
SBP | 0.979 (0.978–0.980) | 91.2% | 93.8% | 95.5 |
DBP | 0.690 (0.687–0.693) | 68.8% | 59.5% | 72.5 |
TC | 0.578 (0.571–0.586) | 61.2% | 51.1% | 5.0 |
TG | 0.782 (0.779–0.785) | 72.7% | 70.1% | 1.3 |
HDL-C | 0.721 (0.718–0.724) | 67.8% | 65.5% | 1.3 |
LDL-C | 0.593 (0.590–0.596) | 54.4% | 60.3% | 3.0 |
